Arcoma AB (Sweden) Performance

ARCOMA Stock  SEK 7.82  0.22  2.89%   
Arcoma AB has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.38, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Arcoma AB are expected to decrease at a much lower rate. During the bear market, Arcoma AB is likely to outperform the market. Arcoma AB right now shows a risk of 2.7%. Please confirm Arcoma AB coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to decide if Arcoma AB will be following its price patterns.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Arcoma AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain fundamental indicators, Arcoma AB may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Begin Period Cash Flow8.6 M
Total Cashflows From Investing Activities-4.2 M
  

Arcoma AB Relative Risk vs. Return Landscape

If you would invest  738.00  in Arcoma AB on November 20, 2025 and sell it today you would earn a total of  44.00  from holding Arcoma AB or generate 5.96% return on investment over 90 days. Arcoma AB is generating 0.1351% of daily returns and assumes 2.702% volatility on return distribution over the 90 days horizon. Simply put, 24% of stocks are less volatile than Arcoma, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Arcoma AB is expected to generate 1.02 times less return on investment than the market. In addition to that, the company is 3.57 times more volatile than its market benchmark. It trades about 0.05 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.18 per unit of volatility.

Arcoma AB Target Price Odds to finish over Current Price

The tendency of Arcoma Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 7.82 90 days 7.82 
under 4
Based on a normal probability distribution, the odds of Arcoma AB to move above the current price in 90 days from now is under 4 (This Arcoma AB probability density function shows the probability of Arcoma Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Arcoma AB has a beta of -0.38. This suggests as returns on the benchmark increase, returns on holding Arcoma AB are expected to decrease at a much lower rate. During a bear market, however, Arcoma AB is likely to outperform the market. Additionally Arcoma AB has an alpha of 0.0856, implying that it can generate a 0.0856 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Arcoma AB Price Density   
       Price  

Predictive Modules for Arcoma AB

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Arcoma AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
5.127.8210.52
Details
Intrinsic
Valuation
LowRealHigh
3.716.419.11
Details

Arcoma AB Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Arcoma AB is not an exception. The market had few large corrections towards the Arcoma AB's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Arcoma AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Arcoma AB within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.09
β
Beta against Dow Jones-0.38
σ
Overall volatility
0.23
Ir
Information ratio 0.01

Arcoma AB Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Arcoma AB for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Arcoma AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
The company reported the revenue of 117.13 M. Net Loss for the year was (7.47 M) with profit before overhead, payroll, taxes, and interest of 55.29 M.
Arcoma AB has accumulated about 811 K in cash with (1.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Roughly 47.0% of the company shares are held by company insiders

Arcoma AB Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Arcoma Stock often depends not only on the future outlook of the current and potential Arcoma AB's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arcoma AB's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding31.4 M
Cash And Short Term Investments4.8 M

Arcoma AB Fundamentals Growth

Arcoma Stock prices reflect investors' perceptions of the future prospects and financial health of Arcoma AB, and Arcoma AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Arcoma Stock performance.

About Arcoma AB Performance

By analyzing Arcoma AB's fundamental ratios, stakeholders can gain valuable insights into Arcoma AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Arcoma AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Arcoma AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscleskeleton, thoratic, pediatric, and traumaresus clinics. Arcoma AB is traded on Stockholm Stock Exchange in Sweden.

Things to note about Arcoma AB performance evaluation

Checking the ongoing alerts about Arcoma AB for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Arcoma AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
The company reported the revenue of 117.13 M. Net Loss for the year was (7.47 M) with profit before overhead, payroll, taxes, and interest of 55.29 M.
Arcoma AB has accumulated about 811 K in cash with (1.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Roughly 47.0% of the company shares are held by company insiders
Evaluating Arcoma AB's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Arcoma AB's stock performance include:
  • Analyzing Arcoma AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Arcoma AB's stock is overvalued or undervalued compared to its peers.
  • Examining Arcoma AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Arcoma AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Arcoma AB's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Arcoma AB's stock. These opinions can provide insight into Arcoma AB's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Arcoma AB's stock performance is not an exact science, and many factors can impact Arcoma AB's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Arcoma Stock analysis

When running Arcoma AB's price analysis, check to measure Arcoma AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcoma AB is operating at the current time. Most of Arcoma AB's value examination focuses on studying past and present price action to predict the probability of Arcoma AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcoma AB's price. Additionally, you may evaluate how the addition of Arcoma AB to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites